Clinical Trials on Parathyroid Neoplasms in South Africa

Total 6552 results

BioSyngen Pte Ltd

Unknown

A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites

Malignant Ascites | Malignant Pleural Effusion

Australia
Professor Michael Bourke

Completed

Soft Coagulation for the Prevention of Adenoma Recurrence (SCAR)

Colonic Adenomas

Australia
Asieris Pharmaceuticals (AUS) Pty Ltd.

Completed

A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets

Bladder Cancer

Australia
Lymphoma Trials Office

Unknown

Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach

Gastric Cancer

United Kingdom, Hong Kong, Switzerland, Poland, South Africa
Asbestos Diseases Research Foundation
EnGeneIC Limited

Completed

MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC

Non-Small Cell Lung Cancer | Malignant Pleural Mesothelioma

Australia
Medical University of South Carolina

Withdrawn

Valproic Acid in Childhood Progressive Brain Tumors

Glioma | Glioblastoma | Medulloblastoma | Anaplastic Astrocytoma | Pediatric Brain Tumor

United States
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer (CheckMate 907)

Non-Small Cell Lung Cancer

United States, Canada, Japan, Romania, South Africa
Shanghai Henlius Biotech

Recruiting

HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors

Non-small Cell Lung Cancer | Locally Advanced or Metastatic Solid Tumors

Australia
Queensland Centre for Gynaecological Cancer
Royal Brisbane and Women's Hospital; The University of Queensland; Queensland... and other collaborators

Completed

Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer (LEGS)

Cervical Cancer | Ovarian Cancer | Endometrial Cancer | Female Genital Diseases | Vulval Cancer

Australia
Medical University of South Carolina

Terminated

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
Medical University of South Carolina
National Cancer Institute (NCI)

Completed

Docetaxel and Lycopene in Metastatic Prostate Cancer

Adenocarcinoma of the Prostate

United States
Medical University of South Carolina

Active, not recruiting

Topical Aldara (Imiquimod) for Oral Cancer

Oral Cancer

United States
Medical University of South Carolina

Terminated

Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer

Gastric Cancer

United States
University of Sydney
Western Sydney Local Health District

Active, not recruiting

Collection of Head Images During Radiotherapy (CHIRP)

Head and Neck Neoplasms | Radiation Therapy Complication

Australia
Virginia Commonwealth University

Recruiting

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Rectal Cancer

United States
Northern Sydney and Central Coast Area Health Service
Merck KGaA, Darmstadt, Germany

Unknown

Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene (ExCentric)

Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4

Australia
AllVascular

Recruiting

Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer (SYS-CAPLIOX)

Liver Metastasis Colon Cancer

Australia
Sung Hyun Pyun

Unknown

Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope

Skin Cancer

Australia
Harry Drabkin

Terminated

Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery

Kidney Cancer

United States
CTI BioPharma

Completed

Phase II CT-2103/Carboplatin in Ovarian Cancer

Ovarian Neoplasm

United States
Medical University of South Carolina
National Cancer Institute (NCI)

Active, not recruiting

Navigation vs Usual Care for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC (NDURE2)

Squamous Cell Carcinoma of Head and Neck

United States
Medical University of South Carolina
National Cancer Institute (NCI)

Completed

Navigation for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC

Squamous Cell Carcinoma of Head and Neck

United States
Medical University of South Carolina

Active, not recruiting

Transdisciplinary Oral/Oropharyngeal Cancer Research & Care in Head and Neck Cancer (TORCH)

Head and Neck Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site

Neoplasm, Unknown Primary

United States
Royal North Shore Hospital

Completed

Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET (PRISM)

Rectal Neoplasms

Australia
Professor Michael Bourke

Recruiting

Long-term Outcomes of Endoscopic Resection (ER) of Lesions of the Duodenum and Ampulla (OERDA)

Adenoma, Villous

Australia
Professor Michael Bourke

Recruiting

Upper GI Outcomes Following EMR (UGI-EMR)

Adenoma, Villous

Australia
Professor Michael Bourke

Active, not recruiting

Comparison Between White Light Endoscopy and Bright Narrow Band Imaging in Diagnosis Colonic Adenomas. (WLEvB-NBI)

Colonic Adenomas

Australia
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; University of Liverpool; University of Newcastle Upon-Tyne and other collaborators

Recruiting

Ii-HANC Improving Incurable Head and Neck Cancer Healthcare Experiences

Head and Neck Cancer

United Kingdom
Professor Michael Bourke

Recruiting

Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach (OERS)

Adenoma, Villous

Australia
VA Office of Research and Development

Completed

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

Mouth Neoplasms

United States
Calvary Mater Newcastle, Australia
Abbott

Completed

PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) (PROCITT)

Prostate Cancer

Australia
Cellxpert Biotechnology Corp.
Medigen Biotechnology Corporation

Completed

Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Australia
University of South Carolina

Recruiting

Reducing Metabolic Dysregulation in Dyads (REMEDY)

Inflammation | Colorectal Cancer | Nutrition Related Cancer

United States
Medical University of South Carolina
Rain Oncology Inc

Terminated

Tarlox and Sotorasib in Patients With KRAS G12C Mutations

Non-Small Cell Lung Cancer

United States
Medical University of South Carolina
Ferring Pharmaceuticals

Active, not recruiting

Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.

Metastatic Prostatic Adenocarcinoma

United States
GlaxoSmithKline

Terminated

Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites

Melanoma and Brain Metastases

United States, Australia
Melanoma and Skin Cancer Trials Limited
University of Oxford; Trans Tasman Radiation Oncology Group

Active, not recruiting

Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma (WBRTMel)

Metastatic Melanoma

Norway, Australia, United Kingdom
Apollomics (Australia) Pty. Ltd.
Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...

Terminated

APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC

Renal Cell Carcinoma | Hepatocellular Carcinoma

Australia, New Zealand
Medical University of South Carolina

Terminated

A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma

Glioma | Astrocytoma | Brain Tumor | Glioblastoma Multiforme

United States
Western Sydney Local Health District
Bristol-Myers Squibb; University of Western Sydney

Recruiting

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity (ICEMELT)

Melanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Gastric Cancer | Mesothelioma | Endometrial Cancer | Lung Cancer, Nonsmall Cell

Australia
Carolina Research Professionals, LLC
Bayer

Completed

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis (eRADicAte)

Prostate Cancer

United States
St Vincent's Hospital, Sydney

Recruiting

Bipolar Androgen Therapy + Carboplatin in mCRPC (HiTeCH)

Castration-resistant Prostate Cancer | Homologous Recombination Deficiency

Australia
Medical University of South Carolina

Completed

Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Pancreatic Cancer

United States
Medical University of South Carolina
Novartis Pharmaceuticals

Completed

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Soft Tissue Sarcoma | Renal Cancer | Non Small Cell Lung Cancer (NSCLC)

United States
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Recruiting

Ex VIvo DEtermiNed Cancer Therapy (EVIDENT)

Melanoma | Sarcoma | Kidney Cancer | Head and Neck Cancer | Glioblastoma | Bladder Cancer

United Kingdom
Medical University of South Carolina

Completed

Single-arm Phase II Study of NDURE for Patients With HNC (NDURE)

Cancer of Head and Neck

United States
Anthony Joshua, FRACP
St Vincent's Hospital, Sydney; Royal Prince Alfred Hospital, Sydney, Australia and other collaborators

Recruiting

Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer (TICTOC)

Ovarian Cancer

Australia
Medical University of South Carolina

Terminated

Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas

Adenocarcinoma Pancreas

United States
AstraZeneca

Completed

KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy) (KOREA)

Non-Small Cell Lung Cancer

Korea, Republic of

Clinical Trials on Parathyroid Neoplasms in South Africa

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations